Lurbinectedin trials for Small Cell Lung Cancer

All Lurbinectedin trials · All Small Cell Lung Cancer trials

Phase breakdown

Recruiting trials studying Lurbinectedin for Small Cell Lung Cancer

• A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
  NCT06203210 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 229 locations
• A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
  NCT07365241 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 63 locations
• Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer
  NCT05800587 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of Trilaciclib and Lurbinectidin
  NCT05578326 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations

Common questions

How many trials study Lurbinectedin for Small Cell Lung Cancer?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.